Skip to content

Nilocin Vorte Gel

by Unigroup ApS Denmark EUDAMED

Ref 101035Model Keratolytic

EMDN V9099

Regulatory status

as of 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR Number57064481010KERATOLYTICJX Basic UDI-DIDate23 Jan 2026RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Not covered

European Union — CE/MDR Active

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 22 Oct 2026

Device Name
Wart & Verruca Gel Treatment, Wart & Verruca Treatment, Molluscum Treatment, Foot Corn Treatment
Model / Reference
Keratolytic, 101035
Primary DI / UDI-DI
05706448000767
Basic UDI-DI
57064481010KERATOLYTICJX
EMDN Code
V9099 Various devices not included in other classes - other
Device Class
Class IIa
Market of Registration
Denmark

Manufacturer details

EUDAMED SRN
DK-MF-000009459

Other devices from Unigroup ApS

See all devices from Unigroup ApS →

Properties & raw data

Show properties, registry sources and raw records
Other properties (13)
  • Sterile: No
  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Endocrine Disruptor: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No

Sources (1)

  • EUDAMED c9de0db4-e172-4c22-bee3-991966479cb1 61 fields · synced 22 Oct 2026